CPC A61K 9/70 (2013.01) [A61K 9/006 (2013.01); A61K 9/0014 (2013.01); A61K 9/0034 (2013.01); A61K 9/0043 (2013.01); A61K 9/0048 (2013.01); A61K 31/00 (2013.01); A61K 31/095 (2013.01); A61K 31/375 (2013.01); A61K 31/66 (2013.01); A61K 31/70 (2013.01); A61K 31/7088 (2013.01); A61K 31/726 (2013.01); A61K 38/02 (2013.01); A61K 38/05 (2013.01); A61K 38/1735 (2013.01); A61K 45/06 (2013.01); A61K 47/42 (2013.01); A61K 48/0075 (2013.01)] | 5 Claims |
1. A composition for modifying a mucous membrane comprising a first agent that physically interacts or reacts with a protein in said mucous membrane and/or its intimately associated adherent thin film, a second agent that promotes holding an aqueous component of said mucous membrane in place, and a physiologically acceptable carrier wherein said first agent is a peptide, polypeptide or protein modified to comprise a heterobifunctional linker and said second agent is a mucin or mucin analog.
|